Back to the community

Moderna behavioral interview questions

Researched interview questions, process detail, and difficulty signals for Moderna, compiled by the Primly research team.

6 experiences Difficulty 3.8/5 Pharma / mRNA

Regulatory Affairs Manager

virtual · Difficulty 4/5

Candidates report starting with a recruiter screen to confirm regulatory scope (US, EU, global), therapeutic area alignment, and experience with submissions and health authority interactions, usually 30 minutes. The next stage is typically a hiring manager interview focused on strategy, stakeholder management across CMC, clinical, safety, and labeling, and examples of navigating accelerated timelines. Many candidates then complete a multi-interviewer virtual loop with 4 to 6 conversations including Regulatory CMC, Clinical Regulatory, project/program leadership, and sometimes Quality or Pharmacovigilance, often scheduled in one day or split across two days. A common feature is a practical case discussion rather than a formal take-home, such as outlining an approach to an upcoming meeting with FDA/EMA or responding to an information request while protecting the program timeline. Final steps often include an interview with a senior regulatory leader to probe judgment, risk framing, and how the candidate influences without authority in a fast-moving environment, with end-to-end timing commonly around 3 to 6 weeks.

  • Explain how you would build a regulatory strategy for an mRNA program moving from early clinical to pivotal, including major submission milestones and key risks you would flag.
  • Describe a time you had to align CMC, clinical, and safety stakeholders on a regulatory position under significant time pressure. What tradeoffs did you make?
  • A health authority asks for additional comparability data after a process change. How would you assess the request and propose a path forward with CMC and Quality?
  • What does a strong briefing package look like for a Type B meeting, and how do you decide what to push for versus defer?
  • How do you communicate regulatory risk in a way that enables fast decisions rather than slowing a team down?

Quality Assurance Specialist

virtual · Difficulty 3/5

Candidates report a recruiter phone screen first, typically 20 to 30 minutes, focused on eligibility to work, location expectations, motivation for Moderna’s mission, and a high-level review of GMP exposure. The next step is commonly a hiring manager video interview, 45 to 60 minutes, testing fundamentals of pharma quality systems (deviations, CAPA, change control, documentation practices) and how the candidate handles urgency in a regulated environment. Many processes then add a virtual panel loop of 3 to 5 interviews over half a day, with cross-functional partners from Quality Operations, Manufacturing, Supply Chain, or Technical Operations. Interviewers often ask for concrete examples of documentation rigor, decision-making under ambiguity, and how the candidate escalates quality risks while supporting speed. Some candidates report a final conversation with a senior quality leader or HR partner to confirm level, culture fit, and logistics, with an overall timeline of about 2 to 5 weeks depending on site needs and headcount urgency.

  • Walk through how you would document and triage a deviation discovered on the manufacturing floor, including what information you would collect first and who you would involve.
  • Describe a time you had to stop or slow down work due to a compliance concern. How did you communicate it, and what was the outcome?
  • If a batch record has a missing entry or unclear correction, what is your next step and what would you avoid doing?
  • How have you used CAPA in the past, and how do you distinguish between immediate correction and root-cause corrective action?
  • Moderna is known for moving quickly. How would you balance speed with quality expectations in day-to-day decisions?

Software Engineer

virtual · Difficulty 3/5

Recruiter screen, coding phone, virtual onsite with coding, system design, deep-dive, and behavioral.

  • Tell me about owning a feature with clinical-trial implications.
  • Describe debugging a regulatory-impacted issue.
  • Walk me through how you'd design a clinical-data platform.
  • How do you partner with clinical teams on a feature?